-
1
-
-
2942666483
-
-
WHO. Available from. [Accessed September 9, 2008].
-
WHO. Diabetes mellitus. 2006. Available from: http://www.who.int/ mediacentre/factsheets/fs312/en/index.html [Accessed September 9, 2008].
-
(2006)
Diabetes Mellitus
-
-
-
3
-
-
33846414720
-
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary. the task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the study of diabetes (EASD)
-
Ryden L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the study of diabetes (EASD). Eur Heart J 2007 28 : 88 136.
-
(2007)
Eur Heart J
, vol.28
, pp. 88-136
-
-
Ryden, L.1
Standl, E.2
Bartnik, M.3
-
4
-
-
0036833536
-
Inside guidelines: Comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries
-
Burgers JS, Bailey JV, Klazinga NS, et al. Inside guidelines: comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries. Diabetes Care 2002 25 : 1933 9.
-
(2002)
Diabetes Care
, vol.25
, pp. 1933-1939
-
-
Burgers, J.S.1
Bailey, J.V.2
Klazinga, N.S.3
-
5
-
-
33645124529
-
NHG-standaard diabetes mellitus type 2 (tweede herziening) (NHG practice guideline diabetes mellitus type 2 (second revision)
-
Rutten GEHM, De Grauw WJC, Nijpels G, et al. NHG-standaard diabetes mellitus type 2 (tweede herziening) (NHG practice guideline diabetes mellitus type 2 (second revision). Huisarts Wet 2006 49 : 137 52.
-
(2006)
Huisarts Wet
, vol.49
, pp. 137-152
-
-
Gehm, R.1
De Grauw, W.J.C.2
Nijpels, G.3
-
6
-
-
33846025092
-
Primary prevention of cardiovascular diseases in people with diabetes mellitus: A scientific statement from the American Heart Association and the American Diabetes Association
-
Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2007 30 : 162 72.
-
(2007)
Diabetes Care
, vol.30
, pp. 162-172
-
-
Buse, J.B.1
Ginsberg, H.N.2
Bakris, G.L.3
-
7
-
-
5344249310
-
The CORE Diabetes Model
-
Suppl.
-
Brandle M, Herman WH. The CORE Diabetes Model. Curr Med Res Opin 2004 20 (Suppl. 1 S1 3.
-
(2004)
Curr Med Res Opin
, vol.20
, Issue.1
, pp. 1-3
-
-
Brandle, M.1
Herman, W.H.2
-
8
-
-
5344261712
-
The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making
-
Suppl.
-
Palmer AJ, Roze S, Valentine WJ, et al. The CORE Diabetes Model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res Opin 2004 20 (Suppl. 1 S5 26.
-
(2004)
Curr Med Res Opin
, vol.20
, Issue.1
, pp. 5-26
-
-
Palmer, A.J.1
Roze, S.2
Valentine, W.J.3
-
9
-
-
5344269410
-
Validation of the CORE Diabetes Model against epidemiological and clinical studies
-
Suppl.
-
Palmer AJ, Roze S, Valentine WJ, et al. Validation of the CORE Diabetes Model against epidemiological and clinical studies. Curr Med Res Opin 2004 20 (Suppl. 1 S27 40.
-
(2004)
Curr Med Res Opin
, vol.20
, Issue.1
, pp. 27-40
-
-
Palmer, A.J.1
Roze, S.2
Valentine, W.J.3
-
10
-
-
0035432608
-
Cardiovascular drug use and hospitalizations attributable to type 2 diabetes
-
Erkens JA, Klungel OH, Stolk RP, et al. Cardiovascular drug use and hospitalizations attributable to type 2 diabetes. Diabetes Care 2001 24 : 1428 32.
-
(2001)
Diabetes Care
, vol.24
, pp. 1428-1432
-
-
Erkens, J.A.1
Klungel, O.H.2
Stolk, R.P.3
-
11
-
-
0026578226
-
Pharmaco-morbidity linkage: A feasibility study comparing morbidity in two pharmacy based exposure cohorts
-
Herings RM, Bakker A, Stricker BH, Nap G. Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health 1992 46 : 136 40.
-
(1992)
J Epidemiol Community Health
, vol.46
, pp. 136-140
-
-
Herings, R.M.1
Bakker, A.2
Stricker, B.H.3
Nap, G.4
-
12
-
-
0033552080
-
The progressive cost of complications in type 2 diabetes mellitus
-
Brown JB, Pedula KL, Bakst AW. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 1999 159 : 1873 80.
-
(1999)
Arch Intern Med
, vol.159
, pp. 1873-1880
-
-
Brown, J.B.1
Pedula, K.L.2
Bakst, A.W.3
-
13
-
-
8644250763
-
Treatment patterns and health care costs of mebeverine-treated IBS patients: A case-control study
-
Goettsch WG, van den Boom G, Breekveldt-Postma NS, et al. Treatment patterns and health care costs of mebeverine-treated IBS patients: a case-control study. Pharmacoepidemiol Drug Saf 2004 13 : 803 10.
-
(2004)
Pharmacoepidemiol Drug Saf
, vol.13
, pp. 803-810
-
-
Goettsch, W.G.1
Van Den Boom, G.2
Breekveldt-Postma, N.S.3
-
14
-
-
0034995403
-
An epidemiological approach to assess the economic burden of NSAID-induced gastrointestinal events in the Netherlands
-
Herings RM, Klungel OH. An epidemiological approach to assess the economic burden of NSAID-induced gastrointestinal events in The Netherlands. Pharmacoeconomics 2001 19 : 655 65.
-
(2001)
Pharmacoeconomics
, vol.19
, pp. 655-665
-
-
Herings, R.M.1
Klungel, O.H.2
-
16
-
-
67651229809
-
-
Statistics-Netherlands-(CBS). Voorburg/Heerlen. Statistics Netherlands (CBS)
-
Statistics-Netherlands-(CBS). Statistisch Jaarboek. Voorburg/Heerlen : Statistics Netherlands (CBS), 2004.
-
(2004)
Statistisch Jaarboek.
-
-
-
17
-
-
43449108812
-
Economic costs of diabetes in the U.S. in 2007
-
American Diabetes Association.
-
American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008 31 : 596 615.
-
(2008)
Diabetes Care
, vol.31
, pp. 596-615
-
-
-
18
-
-
35848942599
-
Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4)
-
Martin S, Schramm W, Schneider B, et al. Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4). Exp Clin Endocrinol Diabetes 2007 115 : 495 501.
-
(2007)
Exp Clin Endocrinol Diabetes
, vol.115
, pp. 495-501
-
-
Martin, S.1
Schramm, W.2
Schneider, B.3
-
19
-
-
41849140781
-
The impact of diabetes on prescription drug costs: The population-based Turin study
-
Bruno G, Karaghiosoff L, Merletti F, et al. The impact of diabetes on prescription drug costs: the population-based Turin study. Diabetologia 2008 51 : 795 801.
-
(2008)
Diabetologia
, vol.51
, pp. 795-801
-
-
Bruno, G.1
Karaghiosoff, L.2
Merletti, F.3
-
20
-
-
0043244907
-
Economic costs of diabetes in the US in 2002
-
Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003 26 : 917 32.
-
(2003)
Diabetes Care
, vol.26
, pp. 917-932
-
-
Hogan, P.1
Dall, T.2
Nikolov, P.3
-
21
-
-
33746415251
-
Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes
-
Eppens MC, Craig ME, Cusumano J, et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 2006 29 : 1300 6.
-
(2006)
Diabetes Care
, vol.29
, pp. 1300-1306
-
-
Eppens, M.C.1
Craig, M.E.2
Cusumano, J.3
-
23
-
-
0042825242
-
Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: The hoorn screening study
-
Spijkerman AM, Dekker JM, Nijpels G, et al. Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study. Diabetes Care 2003 26 : 2604 8.
-
(2003)
Diabetes Care
, vol.26
, pp. 2604-2608
-
-
Spijkerman, A.M.1
Dekker, J.M.2
Nijpels, G.3
|